Psoriasis News

Patients and clinicians agree that as-needed use of biologic therapy has benefits over continuous long-term biologic use for the treatment of psoriasis, according to a study.

Patients treated with interleukin-23i or IL-12/23i for psoriasis exhibited similar rates of risk for developing psoriatic arthritis, according to a study.

The European Commission has granted marketing authorization for two devices that administer Bimzelx for the treatment of multiple inflammatory diseases, UCB announced in a press release.

Poor representation of darker skin tones in dermatology training materials has led to delayed diagnoses and worse treatment outcomes in Black, Asian and non-white Latin American patients, according to a presenter.

Healio has compiled July’s most-read news in dermatology.

The American Skin Association has announced the recipients of its 2024 research grants for skin cancer and diseases, according to a press release.

Arcutis has submitted a supplemental new drug application for Zoryve foam 0.3% for the treatment of scalp and body psoriasis in adults and adolescents aged 12 years and older, according to a company press release.

Patients with psoriasis, specifically those with a high BMI, had lower concentrations of polyunsaturated fatty acids and elevated concentrations of saturated fatty acid, which correlate to greater disease severity, according to a study.

While the art of tattooing has been present for centuries, the medical implications are only recently coming to light with modern medicine.

A higher risk for developing psoriasis was found in subjects who were fed formula as infants compared with those who were breastfed for at least the first 4 months of life, according to a Swedish study.